/Companies

Accretion Therapeutics

Lincolnshire, US · Founded 2026 · Delaware corporation

Find your way into Accretion Therapeutics

Sign up to see every warm intro you have to Accretion Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Accretion Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DH
David HolecekExecutive

Reported raises · per SEC filings

Form D private placements

$750K disclosed across 1 round · 2026

▶$750KraisedFeb 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David HolecekExecutive Officer, Director
Offering amount
$1M
Amount sold
$750K
Minimum investment
$750K
First sale
Feb 2026
Incorporated
Corporation, Delaware, 2026
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Accretion Therapeutics raised?
Accretion Therapeutics has disclosed $750K raised across 1 round.
Where is Accretion Therapeutics headquartered?
Accretion Therapeutics is headquartered in Lincolnshire, US.